The response to vedolizumab in chronic granulomatous disease-related inflammatory bowel disease
Natasha Kamal, Beatriz E. Marciano, Bryan F. Curtin, Anna Strongin, Suk See De Ravin, Athos Bousvaros, Christopher Koh, Harry L. Malech, Steven M. Holland, Christa S. Zerbe, Theo Heller
Topics & Concepts
VedolizumabMedicineInflammatory bowel diseaseChronic granulomatous diseaseDiseaseGranulomatous diseaseInternal medicineImmunologyInflammatory Bowel DiseaseAutoimmune and Inflammatory DisordersPsoriasis: Treatment and Pathogenesis